MEDICLIN Aktiengesellschaft Net Assets
MEDICLIN Aktiengesellschaft net assets. Based on the latest financial reports, MEDICLIN Aktiengesellschaft (MED) has net assets worth €249.63 Million EUR (≈ $291.85 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€879.69 Million ≈ $1.03 Billion USD) and total liabilities (€630.06 Million ≈ $736.61 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. See MEDICLIN Aktiengesellschaft (MED) net asset quality to measure how much of total assets are equity-financed.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €249.63 Million |
| % of Total Assets | 28.38% |
| Annual Growth Rate | 4.3% |
| 5-Year Change | 36.39% |
| 10-Year Change | 37.49% |
| Growth Volatility | 11.22 |
Net Assets of MEDICLIN Aktiengesellschaft (2003–2025)
Net assets of MEDICLIN Aktiengesellschaft from 2003 to 2025. This chart illustrates how MEDICLIN Aktiengesellschaft's net assets have evolved over time, based on quarterly financial data. Also explore MEDICLIN Aktiengesellschaft (MED) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Net Assets for MEDICLIN Aktiengesellschaft (2003–2025)
The table below shows the annual net assets of MEDICLIN Aktiengesellschaft from 2003 to 2025. For live market cap and overall valuation, see how much is MEDICLIN Aktiengesellschaft worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €249.63 Million ≈ $291.85 Million |
+12.07% |
| 2024-12-31 | €222.74 Million ≈ $260.40 Million |
+13.62% |
| 2023-12-31 | €196.03 Million ≈ $229.18 Million |
-6.35% |
| 2022-12-31 | €209.32 Million ≈ $244.72 Million |
+14.37% |
| 2021-12-31 | €183.02 Million ≈ $213.97 Million |
+3.49% |
| 2020-12-31 | €176.85 Million ≈ $206.75 Million |
-7.29% |
| 2019-12-31 | €190.75 Million ≈ $223.00 Million |
-0.34% |
| 2018-12-31 | €191.40 Million ≈ $223.77 Million |
+3.32% |
| 2017-12-31 | €185.26 Million ≈ $216.59 Million |
+2.04% |
| 2016-12-31 | €181.56 Million ≈ $212.27 Million |
+7.35% |
| 2015-12-31 | €169.14 Million ≈ $197.74 Million |
+9.87% |
| 2014-12-31 | €153.95 Million ≈ $179.98 Million |
+1.16% |
| 2013-12-31 | €152.19 Million ≈ $177.92 Million |
-3.08% |
| 2012-12-31 | €157.02 Million ≈ $183.57 Million |
-5.17% |
| 2011-12-31 | €165.59 Million ≈ $193.59 Million |
+0.37% |
| 2010-12-31 | €164.99 Million ≈ $192.89 Million |
+4.91% |
| 2009-12-31 | €157.26 Million ≈ $183.86 Million |
+5.66% |
| 2008-12-31 | €148.84 Million ≈ $174.00 Million |
+42.88% |
| 2007-12-31 | €104.17 Million ≈ $121.79 Million |
+5.82% |
| 2006-12-31 | €98.44 Million ≈ $115.09 Million |
+12.08% |
| 2005-12-31 | €87.83 Million ≈ $102.68 Million |
+7.84% |
| 2004-12-31 | €81.45 Million ≈ $95.22 Million |
-17.56% |
| 2003-12-31 | €98.80 Million ≈ $115.51 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to MEDICLIN Aktiengesellschaft's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 12539083800.0% over the analyzed period, indicating profitable operations and earnings retention.
MEDICLIN Aktiengesellschaft Net Assets Breakdown (December 2025)
MEDICLIN Aktiengesellschaft net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €81.21 Million | 32.62% |
| Common Stock | €47.50 Million | 19.08% |
| Other Comprehensive Income | €-9.16 Million | -3.68% |
| Other Components | €129.39 Million | 51.98% |
| Total Equity | €248.95 Million | 100.00% |
MEDICLIN Aktiengesellschaft Competitors by Market Cap
The table below lists competitors of MEDICLIN Aktiengesellschaft ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
AK Sigorta AS
IS:AKGRT
|
$170.05 Million |
|
Eagle Bancorp Montana Inc
NASDAQ:EBMT
|
$170.06 Million |
|
Daesang Holdings Co Ltd
KO:084690
|
$170.07 Million |
|
Nnit AS
CO:NNIT
|
$170.08 Million |
|
Partron Co. Ltd
KQ:091700
|
$169.94 Million |
|
Asara Resources Ltd
AU:AS1
|
$169.93 Million |
|
Siljansvik AB (publ)
ST:SIVI
|
$169.88 Million |
|
Rockfields Property Indonesia Pt
JK:ROCK
|
$169.87 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in MEDICLIN Aktiengesellschaft's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 222,506,055 to 248,945,667, a change of 26,439,612 (11.9%).
- Net income of 25,486,439 contributed positively to equity growth.
- Dividend payments of 1,900,000 reduced retained earnings.
- Other comprehensive income decreased equity by 9,206,000.
- Other factors increased equity by 12,059,173.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €25.49 Million | +10.24% |
| Dividends Paid | €1.90 Million | -0.76% |
| Other Comprehensive Income | €-9.21 Million | -3.7% |
| Other Changes | €12.06 Million | +4.84% |
| Total Change | €- | 11.88% |
Book Value vs Market Value Analysis
This analysis compares MEDICLIN Aktiengesellschaft's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.99x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 1.66x to 0.99x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2003-12-31 | €3.14 | €5.20 | x |
| 2004-12-31 | €2.69 | €5.20 | x |
| 2005-12-31 | €2.77 | €5.20 | x |
| 2006-12-31 | €3.13 | €5.20 | x |
| 2007-12-31 | €3.25 | €5.20 | x |
| 2008-12-31 | €4.59 | €5.20 | x |
| 2009-12-31 | €3.31 | €5.20 | x |
| 2010-12-31 | €3.47 | €5.20 | x |
| 2011-12-31 | €3.49 | €5.20 | x |
| 2012-12-31 | €3.31 | €5.20 | x |
| 2013-12-31 | €3.21 | €5.20 | x |
| 2014-12-31 | €3.25 | €5.20 | x |
| 2015-12-31 | €3.57 | €5.20 | x |
| 2016-12-31 | €3.83 | €5.20 | x |
| 2017-12-31 | €3.91 | €5.20 | x |
| 2018-12-31 | €4.03 | €5.20 | x |
| 2019-12-31 | €4.02 | €5.20 | x |
| 2020-12-31 | €3.73 | €5.20 | x |
| 2021-12-31 | €3.86 | €5.20 | x |
| 2022-12-31 | €4.40 | €5.20 | x |
| 2023-12-31 | €4.12 | €5.20 | x |
| 2024-12-31 | €4.68 | €5.20 | x |
| 2025-12-31 | €5.24 | €5.20 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently MEDICLIN Aktiengesellschaft utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 10.24%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 3.25%
- • Asset Turnover: 0.89x
- • Equity Multiplier: 3.53x
- Recent ROE (10.24%) is above the historical average (2.11%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2003 | -17.16% | -4.51% | 0.99x | 3.84x | €-26.84 Million |
| 2004 | -19.53% | -4.44% | 0.99x | 4.44x | €-24.05 Million |
| 2005 | 9.21% | 2.10% | 1.38x | 3.18x | €-671.05K |
| 2007 | 5.50% | 1.46% | 1.45x | 2.59x | €-4.69 Million |
| 2008 | 4.89% | 1.59% | 1.33x | 2.31x | €-7.61 Million |
| 2009 | 6.59% | 2.20% | 1.41x | 2.12x | €-5.37 Million |
| 2010 | 6.12% | 2.07% | 1.45x | 2.04x | €-6.39 Million |
| 2011 | 1.80% | 0.60% | 1.50x | 1.99x | €-13.58 Million |
| 2012 | -0.89% | -0.28% | 1.59x | 2.03x | €-17.11 Million |
| 2013 | -1.73% | -0.51% | 1.65x | 2.05x | €-17.88 Million |
| 2014 | 5.51% | 1.58% | 1.68x | 2.07x | €-6.93 Million |
| 2015 | 9.76% | 2.98% | 1.69x | 1.94x | €-412.85K |
| 2016 | 9.10% | 2.85% | 1.67x | 1.91x | €-1.64 Million |
| 2017 | 2.11% | 0.64% | 1.65x | 1.99x | €-14.65 Million |
| 2018 | 4.03% | 1.20% | 1.45x | 2.32x | €-11.44 Million |
| 2019 | 5.06% | 1.44% | 0.75x | 4.70x | €-9.44 Million |
| 2020 | -5.08% | -1.36% | 0.74x | 5.01x | €-26.71 Million |
| 2021 | 0.80% | 0.22% | 0.76x | 4.81x | €-16.87 Million |
| 2022 | 4.51% | 1.34% | 0.77x | 4.38x | €-11.48 Million |
| 2023 | -5.50% | -1.48% | 0.83x | 4.49x | €-30.37 Million |
| 2024 | 11.16% | 3.32% | 0.83x | 4.07x | €2.59 Million |
| 2025 | 10.24% | 3.25% | 0.89x | 3.53x | €591.87K |
Industry Comparison
This section compares MEDICLIN Aktiengesellschaft's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $4,202,706,718
- Average return on equity (ROE) among peers: -12.05%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| MEDICLIN Aktiengesellschaft (MED) | €249.63 Million | -17.16% | 2.52x | $170.05 Million |
| China Resources Medical Holdings Company Limited (1PH) | $5.60 Billion | 7.52% | 0.23x | $354.05 Million |
| AEST.MED.INT.HLD.SP.ADR/3 (3FMA) | $33.63 Million | -111.31% | 15.67x | $3.30 Million |
| JINXIN FERT.GRP HD-00001 (3NX) | $10.19 Billion | 3.38% | 0.46x | $582.53 Million |
| REVITALIST L.A.W. LTD (4DO) | $-11.05 Million | 0.00% | 0.00x | $744.60K |
| Wenzhou Kangning Hospital Co. Ltd (4WK) | $1.21 Billion | 6.69% | 0.53x | $24.95 Million |
| HYGEIA HC HLDGS DL-00001 (50I) | $4.48 Billion | 9.86% | 0.49x | $11.91K |
| COMPASS PATHW SP.ADR (5Y6) | $181.28 Million | -50.48% | 0.09x | $657.30 Million |
| Bumrungrad Hospital Public Company Limited (BZ7A) | $18.84 Billion | 6.39% | 0.29x | $54.20K |
| GUANGDONG KANG.CO.LTD YC1 (E9Q) | $1.50 Billion | 8.08% | 0.75x | $15.19 Million |
| Eifelhöhen-Klinik AG (EIF) | $17.70 Million | -0.65% | 2.43x | $10.05 Million |
About MEDICLIN Aktiengesellschaft
MEDICLIN Aktiengesellschaft operates hospitals in Germany. The company operates through Post-Acute; Acute; and Nursing Care and Service segments. It offers medical services in the areas of neurology; psychosomatics; orthopedics; internal medicine; cardiology; oncology; geriatrics; psychiatry; otorhinolaryngology; cardiac medicine; rheumatology; gynecology; trauma, heart, and general surgeries; ur… Read more